Clinical trial
Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in…
NCT00185783 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00185783 |
|---|---|
| Title | Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis |
| Official title | Pilot Study of White Blood Cell Gene Expression in Critically Ill Patients With Severe Sepsis and Relative Adrenal Insufficiency After Hydrocortisone Administration |
| Lead sponsor | Stanford University, Other |
| Collaborators | University of Toronto University of Colorado, Denver |
| Status | Completed |
| Study type | Observational |
| Conditions | Sepsis, Relative Adrenal Insufficiency |
| Intervention type | Drug |
| Interventions | Hydrocortisone Administration (Standard of Care Therapy) |
| Enrollment | 10 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: